A Phase I Randomized, Open-Label, Two-Period, Two-Sequence Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Levoketoconazole in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2019
Price : $35 *
At a glance
- Drugs Levoketoconazole (Primary)
- Indications Cushing syndrome
- Focus Pharmacokinetics
- Sponsors Strongbridge Biopharma
- 31 Jan 2019 Status changed from active, no longer recruiting to completed.
- 21 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Dec 2018 New trial record